Transit Therapeutics, Inc.
PrivateCompany Overview
Transit Therapeutics, Inc. is a biotechnology company that develops protein-free trans-splicing of pre-mRNA to create therapeutic treatments for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
trans-splicingpre-mRNAgenetic medicineRNA therapeuticsgene therapyCNS therapeuticsbiotech licensinggenomic integrationdrug discoveryprecision medicinebiotech startupstealth biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transit Therapeutics, Inc. Comparables
Compare Transit Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tacit Therapeutics | 87% | |
| Ascidian Therapeutics | 81% | |
| Amber Bio | 79% | |
Transit Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Transit Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transit Therapeutics, Inc.'s valuation, stock price, and market status.
See something wrong or outdated?